In this issue:
Usefulness of TE in HBeAg-negative disease
Entecavir first choice for HBeAg-positive CHB
Improving HCV screening criteria in France
Green tea improves liver fibrosis?
Risk factors for recurrence in HBV-related HCC
Who to re-treat with PEG-IFN + RBV?
HCV in prison syringes
Treating chronic HCV during methadone maintenance
Time to make HCV a notifiable disease?
Safe to treat HCV in major depressive disorder
Please login below to download this issue (PDF)